Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriana C Vidal

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Aging|May 30, 2015
Aspirin and prostate cancer preventionAdriana C Vidal, Stephen J Freedland
European Urology|October 25, 2016
Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular SubtypingAdriana C Vidal, Stephen J Freedland
Asian Journal of Andrology|March 9, 2017
Re: Commentary on "The association between sexual function and prostate cancer risk in US veterans"Adriana C Vidal, Stephen J Freedland
European Urology|February 11, 2014
Genetic variants in predicting aggressive prostate cancer: "ready for prime time?"Adriana C Vidal, Stephen J Freedland
European Urology|October 1, 2013
Can we eat our way to a lower prostate cancer risk, and if so, how?Adriana C Vidal, Stephen J Freedland
European Urology|October 12, 2013
Words of wisdom. Re: Low serum neutrophil count predicts a positive prostate biopsyEmanuela Taioli, Stephen J Freedland, Adriana C Vidal
Expert Review of Anticancer Therapy|September 25, 2015
Vasectomy: potential links to an increased risk of aggressive prostate cancer?Alexis R Gaines, Adriana C Vidal, Stephen J Freedland
Oncology (Williston Park, N.Y.)|September 20, 2015
Should Men Diagnosed With Prostate Cancer Hit the Gym?Tom S Feng, Adriana C Vidal, Stephen J Freedland
International Journal of Urology : Official Journal of the Japanese Urological Association|September 12, 2014
Editorial Comment to Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgeryRoss M Simon, Stephen J Freedland, Adriana C Vidal
BMC Cardiovascular Disorders|December 20, 2024
Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patientsSabine Hazan, Adriana C Vidal, Nicolas Hulscher, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Aging|May 30, 2015
Aspirin and prostate cancer preventionAdriana C Vidal, Stephen J Freedland
European Urology|October 25, 2016
Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular SubtypingAdriana C Vidal, Stephen J Freedland
Asian Journal of Andrology|March 9, 2017
Re: Commentary on "The association between sexual function and prostate cancer risk in US veterans"Adriana C Vidal, Stephen J Freedland
European Urology|February 11, 2014
Genetic variants in predicting aggressive prostate cancer: "ready for prime time?"Adriana C Vidal, Stephen J Freedland
European Urology|October 1, 2013
Can we eat our way to a lower prostate cancer risk, and if so, how?Adriana C Vidal, Stephen J Freedland
European Urology|October 12, 2013
Words of wisdom. Re: Low serum neutrophil count predicts a positive prostate biopsyEmanuela Taioli, Stephen J Freedland, Adriana C Vidal
Expert Review of Anticancer Therapy|September 25, 2015
Vasectomy: potential links to an increased risk of aggressive prostate cancer?Alexis R Gaines, Adriana C Vidal, Stephen J Freedland
Oncology (Williston Park, N.Y.)|September 20, 2015
Should Men Diagnosed With Prostate Cancer Hit the Gym?Tom S Feng, Adriana C Vidal, Stephen J Freedland
International Journal of Urology : Official Journal of the Japanese Urological Association|September 12, 2014
Editorial Comment to Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgeryRoss M Simon, Stephen J Freedland, Adriana C Vidal
BMC Cardiovascular Disorders|December 20, 2024
Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patientsSabine Hazan, Adriana C Vidal, Nicolas Hulscher, et al.
Pageof 8